(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

X

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

X

ST13

US500000079427008

Class

5

Filing

79427008

Registration

8073007

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

29

Latest update

07/23/2026

Trademark type

Combined

Nice classes

5

Filing date

04/02/2025

Registration date

12/23/2025

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

12/23/2025

Last transaction

07/23/2026

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Drawing code

3

Owner type

25

Owner location

CH

Examiner

PEISECKI, MARK A

Law office

L50

Current location

FILE REPOSITORY (FRANCONIA)

Mark description

The mark consists of a stylized "X" comprised of two intersecting lines, the lines that form the "X" are wide with the one on the upper left slightly longer than the one on the upper right, two elongated thin lines extend outward from each side of the lower part of the "X", two stylized chevrons appear on either side of the origin point of the "X", the chevon on the left is wide at the bottom and thin on the side that extends back and to the left, the chevron on the right is wide at the bottom and thin on the side that extends back and to the right.

Holders and representatives

Holders

NOVARTIS AG

Representatives

Maury M. Tepper, III Tepper & Eyster, PLLC

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune systemthe metabolic systemthe endocrine systemthe musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma

Publications

History of USPTO decisions and trademark events.

29 publications found

FINV

FINAL DECISION TRANSACTION PROCESSED BY IB

07/23/2026

FICS

FINAL DISPOSITION NOTICE SENT TO IB

07/04/2026

FIMP

FINAL DISPOSITION PROCESSED

07/04/2026

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

03/23/2026

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

12/23/2025

R.PR

REGISTERED-PRINCIPAL REGISTER

12/23/2025

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

11/04/2025

PUBO

PUBLISHED FOR OPPOSITION

11/04/2025

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

10/29/2025

RFNT

REFUSAL PROCESSED BY IB

10/10/2025

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

10/07/2025

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

10/02/2025

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

10/02/2025

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

10/02/2025

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

09/29/2025

ECDR

TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS

09/29/2025

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

09/29/2025

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

09/29/2025

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

09/29/2025

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

09/29/2025

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

09/24/2025

RFRR

REFUSAL PROCESSED BY MPU

09/24/2025

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

08/12/2025

CNRT

NON-FINAL ACTION WRITTEN

08/11/2025

DOCK

ASSIGNED TO EXAMINER

08/02/2025

MAFR

APPLICATION FILING RECEIPT MAILED

07/17/2025

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

07/17/2025

LIMI

LIMITATION FROM ORIGINAL APPLICATION ENTERED

07/05/2025

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

07/03/2025

Continuous trademark protection

Get notified about every new filing that threatens X or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.